SCHEMBL7044148

SCHEMBL7044148

NCCc1ccccc1-c1ccccn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.50
KDM4E B2RXH2 4/20 0.46
LMNA P02545 3/20 0.46
CCR1 P32246 2/20 0.46
CCR5 P51681 2/20 0.46
CCR8 P51685 2/20 0.46
CYP1A2 P05177 1/20 0.46
POLB P06746 1/20 0.46
METAP1 P53582 1/20 0.46
BLM P54132 1/20 0.46
HIF1A Q16665 1/20 0.46
DOHH Q9BU89 1/20 0.46
P4HTM Q9NXG6 1/20 0.46
HTT P42858 4/20 0.44
L3MBTL1 Q9Y468 4/20 0.44
ALOX15 P16050 3/20 0.44
USP2 O75604 1/20 0.44
TSHR P16473 1/20 0.44
TAAR1 Q96RJ0 6/20 0.44
DPP4 P27487 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24888335 0.88 KDM4E (0.54) KDM4ELMNACCR1CCR5CCR8
SCHEMBL29496884 0.85 KDM4E (0.50) KDM4ELMNACCR1CCR5CCR8
SCHEMBL3790206 0.85 KDM4E (0.50) KDM4ELMNACCR1CCR5CCR8
SCHEMBL14678660 0.81 KDM4E (0.46) KDM4ELMNACCR1CCR5CCR8
SCHEMBL10358887 0.81 KDM4E (0.46) KDM4ELMNACCR1CCR5CCR8
Ethylene SCHEMBL27759749 0.81 DPP4 (0.47) KDM4ELMNACCR1CCR5CCR8
SCHEMBL1130362 0.81 KDM4E (0.46) KDM4ELMNACCR1CCR5CCR8
SCHEMBL27834816 0.81 KDM4E (0.46) KDM4ELMNACCR1CCR5CCR8
SCHEMBL21666537 0.80 KDM4E (0.54) KDM4ELMNACCR1CCR5CCR8
SCHEMBL4727994 0.80 L3MBTL1 (0.65) KDM4ELMNACCR1CCR5CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0659737-B1 Catecholamine surrogates useful as beta 3 agonists BRISTOL MYERS SQUIBB CO (US) 2003-03-26 EP disclosed
US-5776983-A ANTIDIABETIC AGENTS, OBESITY, GASTROINTESTINAL DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-07-07 US disclosed
EP-0659737-A2 Catecholamine surrogates useful as B3 agonists BRISTOL-MYERS SQUIBB COMPANY (US) 1995-06-28 EP disclosed
EP-0322582-A2 4-Heteroaryl-1,3-Benzodiazepines and 2-substituted-alpha-(heteroaryl)benzeneethanamines, a process for their preparation and their use us medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1989-07-05 EP disclosed